Skip to main content
S&P 5007,549.94+2.35%DOW52,389.75+2.15%NASDAQ25,253.14+2.74%BTC$73,841.00-1.10%ETH$2,068.65-2.43%GOLD$4,065.40-1.19%OIL$84.36-2.87%
Smart Investors Daily
SID Premium
AVITA Medical, Inc. logo

OTC · AVHHL

AVITA Medical, Inc.

Healthcare · Medical - Devices

$3.33

Up+$0.00 (+0.00%)

Updated Nov 10, 2026, 1:50 PM

SID Score

5.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
97.76M
P/E ratio
-1.8
Dividend yield
0.00%
52-week range
$0.00 – $4.01
Volume
444
Avg. volume
133

Price performance · AVHHL

AVHHL price history

1M range · 8 trading sessions · Daily adjusted prices

Prices through Nov 5, 2026

AVHHL closed at $3.33 after 8 trading sessions, up 48.00% for the selected period.

Last close
$3.33
Period change
+48.00%
Period low
$2.25
Period high
$3.33
Daily close
View OHLC price history
AVHHL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 5, 2026$3.33$3.33$3.33$3.33444
Nov 4, 2026$3.33$3.33$3.33$3.33500
Oct 30, 2026$3.10$3.10$3.10$3.10750
Oct 29, 2026$2.85$2.85$2.85$2.85100
Oct 23, 2026$2.79$2.79$2.79$2.79375
Oct 22, 2026$2.93$2.96$2.93$2.96250
Oct 20, 2026$2.25$2.25$2.25$2.25100
Oct 12, 2026$2.25$2.25$2.25$2.25300

Latest AVHHL news

The latest Smart Investors Daily articles mentioning AVHHL.

Stock researchCompany · Overview

AVHHL research

Overview

Company profile and research snapshot.

Company profile

AVITA MED INC CDI

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
AVHHL recent ratings
DateFirmRatingTarget
Nov 6, 2026BTIGBuy—
Nov 6, 2026Lake StreetBuy—
Oct 12, 2026BTIGBuy—
Aug 28, 2026Lake StreetBuy—
Aug 19, 2026TD CowenBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 26, 2026

What AVITA Medical Holders Bought Into Before A 347% Run

If you only skimmed the Medicare reimbursement headaches and net losses around AVITA Medical at the start of 2026, this outcome would be hard to guess. Holding AVITA Medical from the start of the year would have returned 347.0%, including dividends. Revenue and net margin both improved by Q2 2026, yet the swing in shareholder wealth far outpaced those accounting gains. If you had known only what was on record in early January, how would you have weighed that risk against this...

Yahoo · Oct 20, 2026

AVITA Medical to Announce Third Quarter 2026 Financial Results

VALENCIA, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will report its third quarter 2026 financial results after the close of the U.S. financial markets on Thursday, November 5, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, November 6, 2026, at 8:30 a.m.

Yahoo · Oct 1, 2026

AVITA Medical (RCEL) Stock Sees Fair Value Lift After PermeaDerm Data And Q2 Beat

AVITA Medical’s updated valuation work now points to a fair value of $12.29, compared with the prior $11.06, which gives you a fresh reference point for where analysts see the stock’s central value today. The shift lines up with commentary that has turned more constructive after the PermeaDerm I data, recent quarterly results, and a view that current evidence and reimbursement trends support a higher fair valuation range. Read on to see what is driving this evolving narrative and how to track...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By